Botanix Pharmaceuticals Limited (ASX:BOT)
Australia · Delayed Price · Currency is AUD 0.0630
0.00 (0.00%)
At close: Feb 19, 2026
Botanix Pharmaceuticals Market Cap
Botanix Pharmaceuticals has a market cap or net worth of 124.12 million as of February 18, 2026. Its market cap has decreased by -83.81% in one year.
Market Cap
124.12M
Enterprise Value
60.37M
Revenue
5.79M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.06
Market Cap Chart
Since July 15, 2016, Botanix Pharmaceuticals's market cap has increased from 12.26M to 124.12M, an increase of 912.00%. That is a compound annual growth rate of 27.26%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 18, 2026 | 124.12M | -53.29% |
| Dec 31, 2025 | 265.72M | -66.39% |
| Dec 31, 2024 | 790.67M | 168.97% |
| Dec 29, 2023 | 293.96M | 367.07% |
| Dec 30, 2022 | 62.94M | 15.49% |
| Dec 31, 2021 | 54.50M | -55.20% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
| Jul 15, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Racura Oncology | 397.56M |
| Dimerix | 297.20M |
| Orthocell | 249.60M |
| Starpharma Holdings | 209.96M |
| Tetratherix | 187.83M |
| Recce Pharmaceuticals | 170.62M |
| Actinogen Medical | 145.40M |
| Paradigm Biopharmaceuticals | 132.30M |